Impact of a Mediterranean diet on hepatic and metabolic outcomes in <scp>non‐alcoholic</scp> fatty liver disease: The <scp>MEDINA</scp> randomised controlled trial

Abstract

There were no between-group differences for hepatic and metabolic outcomes when comparing MedDiet to LFD. LFD improved IHL and insulin resistance. Significant improvements in visceral fat were seen within both groups. This study highlights provision of dietary interventions in free-living adults with NAFLD is challenging.